Amplia Therapeutics Limited (ASX: ATX) Share Price and News

Price

$0.13

Movement

0.01 (+8.33%)

As at 7 Nov - Closed (20 mins delayed)

52 Week Range

$0.049 - $0.425

 
1 Year Return

+42.86%

Amplia Therapeutics Limited Chart and Price Data

$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50

Fundamentals Data provided by Morningstar.

Share Price

$0.13

Day Change

0.01 (+8.33%)

52 Week Range

$0.049 - $0.425

Yesterday's Close

$0.12

Today's Open

$0.12

Days Range

$0.12 - $0.13

Volume

220,421

Avg. Volume (1 month)

1,406,837

Turnover

$27,611

As at 7 Nov - Closed

  • Amplia Therapeutics Limited (ASX: ATX)
    Latest News

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    2 ASX biotech shares rocketing more than 40% on big news

    These two ASX healthcare companies have exciting news for investors today.

    Read more »

    A medical researcher in a white coat holds laboratory equipment and smiles.
    Share Market News

    Why the Amplia (ASX:ATX) share price is rocketing 41% higher today

    The Australian pharmaceutical company sees its share price jump after good news on a drug trial.

    Read more »

    woman in lab coat conducting testing representing biotech
    Share Market News

    Here's why the Amplia (ASX:ATX) share price is up 9% today

    The Amplia Therapeutics Ltd (ASX: ATX) share price is running 9% higher today following progress on its AM945 inhibitor. Here's…

    Read more »

    Share Market News

    Amplia Therapeutics share price up 16% in 2 days as former Macquarie CEO takes substantial stake

    The Amplia Therapetics Ltd (ASX: ATX) share price has risen16% since Tuesday following an announcement that a former Macquarie CEO…

    Read more »

    a woman
    Share Market News

    US congressman resigns over ASX insider trading penny stock scandal

    Can you make money in penny stocks?

    Read more »

    a woman
    Share Market News

    ASX Watergate Arrest: The alleged insider trading at Innate Immunotherapeutics Ltd (ASX:IIL)

    A US Congressman and former director of Innate Immunotherapeutics Ltd (ASX:IIL) has been arrested for conspiracy to commit securities fraud.

    Read more »

    a woman
    Investing

    Cann Group Ltd is one of 64 new shares added to the All Ordinaries this quarter

    Cann Group Ltd (ASX:CAN) shares are one of 64 new additions to the All Ordinaries (Index:^AXAO) (ASX:XAO) this month. Here's…

    Read more »

    a woman
    Investing

    Were these the 3 worst shares on the ASX in 2017?

    The iSentia Group Ltd (ASX:ISD) share price was one of three that destroyed the wealth of unlucky shareholders in 2017…

    Read more »

    a woman
    Investing

    These are the 5 biggest losers on the All Ordinaries in the last 12 months

    The Quintis Ltd (ASX:QIN) share price is amongst the five biggest losers on the All Ordinaries (Index:^AXAO) (ASX:XAO) over the…

    Read more »

    a woman
    Investing

    One crucial thing to consider before investing in risky biotech shares

    Consider this before owning shares in companies like Resapp Health Ltd (ASX:RAP) and Innate Immunotherapeutics Ltd (ASX:IIL).

    Read more »

    a woman
    Investing

    The 3 biggest investing mistakes you can make

    Buying Commonwealth Bank of Australia (ASX:CBA) and Wesfarmers Ltd (ASX:WES) shares may sound boring, but it’s better than some alternatives.

    Read more »

    a woman
    Investing

    Here's how to get rich quick (and stay poor forever)

    Buying speculative stocks like Innate Immunotherapeutics Ltd (ASX:IIL) and Resapp Health Ltd (ASX:RAP) is not a reliable way to grow…

    Read more »

    ATX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    31st Oct 2025 2025-10-31T08:19:02 Amplia Commences Trading on U.S. OTCQB Venture MarketYesNo8:19am2120k
    29th Oct 2025 2025-10-29T09:03:38 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:03am9272k
    28th Oct 2025 2025-10-28T09:13:19 Amplia Receives R&D Tax Rebate Totalling $3.77 MillionYesNo9:13am2105k
    17th Oct 2025 2025-10-17T10:33:02 Amplia Therapeutics to Significantly Expand U.S. PresenceYesNo10:33am2134k
    9th Oct 2025 2025-10-09T08:24:54 ADDITIONAL RESPONSES IN ACCENT PANCREATIC CANCER TRIALYesNo8:24am3216k
    8th Oct 2025 2025-10-08T09:48:10 Notification of cessation of securities - ATXYesNo9:48am413k
    30th Sep 2025 2025-09-30T08:36:02 Patent Allowance for Key Narmafotinib Patent in USYesNo8:36am2151k
    8th Sep 2025 2025-09-08T12:22:43 Change of Director's Interest Notice - Warwick TongYesNo12:22pm4387k
    8th Sep 2025 2025-09-08T12:21:42 Change of Director's Interest Notice - Chris BurnsYesNo12:21pm4383k
    8th Sep 2025 2025-09-08T12:20:57 Change of Director's Interest Notice - Robert PeachYesNo12:20pm4384k

    Profile

    since

    Note